References

Cancer statistics, 2025

2025 · External reference

National Cancer Institute Cancer of the thyroid – cancer stat facts

2026 · External reference

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines taskforce

10.1089/thy.2006.16.109 · 2006 · External reference

Dynamic risk assessment in patients with differentiated thyroid cancer

10.1530/erc-19-0213 · 2019 · External reference

Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American thyroid association staging system

10.1089/thy.2010.0178 · 2010 · External reference

Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies

10.1007/s40618-018-0884-2 · 2018 · External reference

Update on differentiated thyroid cancer staging

10.1016/j.ecl.2014.02.010 · 2014 · External reference

Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine

10.1210/jc.2015-4290 · 2016 · External reference

Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma

10.1530/eje-13-0524 · 2014 · External reference

Dynamic risk stratification integrated with ATA risk system for predicting long-term outcome in papillary thyroid cancer

10.3390/cancers15184656 · 2023 · External reference

2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer

10.1089/thy.2015.0020 · 2016 · External reference

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer

10.1177/10507256251363120 · 2025 · External reference

Thyroid-differentiated and anaplastic carcinoma

2017 · External reference

The definition of recurrence of differentiated thyroid cancer: a systematic review of the literature

10.1089/thy.2024.0271 · 2024 · External reference

R: A language and environment for statistical computing

2025 · External reference

SankeyMATIC: A Sankey diagram builder for everyone

2015 · External reference

Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial

10.1016/s0140-6736(25)00629-4 · 2025 · External reference

Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial

10.1016/s2213-8587(24)00276-6 · 2025 · External reference

Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial

10.1016/s2213-8587(18)30306-1 · 2019 · External reference

Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial

10.1016/s2213-8587(18)30113-x · 2018 · External reference

Dynamic risk stratification in papillary thyroid carcinoma measuring 1 to 4 Cm

10.1002/jso.25182 · 2018 · External reference

A follow-up strategy for patients with an excellent response to initial therapy for differentiated thyroid carcinoma: less is better

10.1089/thy.2017.0130 · 2018 · External reference

The frequency of differentiated thyroid cancer recurrence in 2302 patients with excellent response to primary therapy

10.1210/clinem/dgad571 · 2024 · External reference

Frequent screening with serial neck ultrasound is more likely to identify false-positive abnormalities than clinically significant disease in the surveillance of intermediate risk papillary thyroid cancer patients without suspicious findings on Follow-Up ultrasound evaluation

10.1210/jc.2014-3651 · 2015 · External reference

Limited utility of routine surveillance ultrasound in differentiated thyroid cancer patients with undetectable postoperative thyroglobulin levels

10.1111/cen.15198 · 2025 · External reference

Serial neck ultrasound is more likely to identify false-positive abnormalities than clinically significant disease in low-risk papillary thyroid cancer patients

10.4158/ep15851.or · 2015 · External reference

Analysis of postoperative ultrasonography surveillance after total thyroidectomy in patients with papillary thyroid carcinoma: a multicenter study

10.1177/0284185117700448 · 2018 · External reference

Contribution of neck ultrasonography to patient management in patients with differentiated thyroid carcinoma with excellent response to therapy

10.1007/s12020-024-04147-x · 2024 · External reference

Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence

10.1136/bmj.i3839 · 2016 · External reference

Outcomes of 756 patients with differentiated thyroid cancer and excellent response to treatment: an evidence-based paradigm for long-term surveillance strategies

10.1111/cen.14549 · 2022 · External reference

Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound

10.1210/jc.2019-00962 · 2019 · External reference

Consideration of early dynamic risk stratification to guide discharge from oncologic Follow-Up in patients with differentiated thyroid cancer

10.1089/thy.2024.0119 · 2024 · External reference

Determinants of physicians’ risk-benefit perceptions of adjuvant radioactive iodine for differentiated thyroid cancer

10.1007/s12020-026-04717-1 · 2026 · External reference